NCT05939362View on ClinicalTrials.gov

New Imaging Biomarkers Predictive of MA Progression

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

October 2, 2027

Study Completion Date

January 15, 2028

Conditions
Alzheimer DiseaseMagnetic Resonance SpectroscopyUltra High Field 7TProgression of DiseaseMR Biomarkers
Interventions
OTHER

MRI follow-up

MRI follow-up for patient with early onset Alzheimer's disease

Trial Locations (1)

Unknown

RECRUITING

Chu Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER